Literature DB >> 1936027

Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis.

D Horstkotte1, R Niehues, B E Strauer.   

Abstract

Commissural fusion, leaflet thickening and alteration of the subvalvular apparatus are dominant mechanisms causing clinically important mitral stenosis (MS) of rheumatic origin. Calcification and a consequent decrease in leaflet mobility are subsequent features in rheumatic MS and may be the primary mechanisms in MS of degenerative origin. In 1051 consecutive patients with pure or predominant MS requiring surgical intervention, aetiology was rheumatic in 76.9%, infective in 3.3%, degenerative (severe annular and leaflet calcification) in 2.7% and congenital (Lutembacher syndrome) in 1.2%; it was the result of systemic lupus erythematosus (n = 4), carcinoid heart disease (n = 2), endomyocardial fibrosis (n = 2) and rheumatoid arthritis (n = 2) in less than 1%, while in 14.5% of these patients aetiology remained unclassified. The natural history of rheumatic MS is characterized by an asymptomatic latent period, following the initial rheumatic fever (RF). In a prospective study of MS (n = 159) the mean interval between RF and the appearance of symptoms was 16.3 +/- 5.2 years. Twenty-five years after the initial RF 8% of the patients were still asymptomatic, 9% were class II (NYHA), 33% class III and 50% had been operated or were class IV. Progress from mild to severe disability took 9.2 +/- 4.3 years on average. When valve surgery was indicated but refused by the patients, survival with medical treatment was 0.44 +/- 0.06 after 5 years, 0.32 +/- 0.08 after 10 years and 0.19 +/- 0.09 after 15 years.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1936027     DOI: 10.1093/eurheartj/12.suppl_b.55

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  17 in total

Review 1.  Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature.

Authors:  C Langer; C Piper; J Vogt; J Heintze; T Butz; O Lindner; W Burchert; C Kersting; D Horstkotte
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

Review 2.  Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity.

Authors:  Soumya D Chakravarty; John B Zabriskie; Allan Gibofsky
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

3.  [Current standard in diagnosis and therapy of heart valve lesions].

Authors:  S Reith; H Körtke; O Volk; H G Klues
Journal:  Z Kardiol       Date:  2001-12

4.  Medium-term outcomes of 78,808 patients after heart valve surgery in a middle-income country: a nationwide population-based study.

Authors:  Regina Maria de Aquino Xavier; Vitor Manuel Pereira Azevedo; Paulo Henrique Godoy; Arn Migowski; Antonio Luiz Pinho Ribeiro; Rogério Brant Martins Chaves; Marcelo Goulart Correia; Carolina de Aquino Xavier; Lucas de Aquino Hashimoto; Clara Weksler; Nelson Albuquerque Souza E Silva
Journal:  BMC Cardiovasc Disord       Date:  2017-12-28       Impact factor: 2.298

Review 5.  Indication and timing of percutaneous mitral balloon valvotomy and the role of atrial fibrillation.

Authors:  J Langerveld; J M P G Ernst; N M van Hemel; W Jaarsma
Journal:  Neth Heart J       Date:  2005-01       Impact factor: 2.380

6.  Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-01       Impact factor: 2.300

7.  Atrial Fibrillation and Early Clinical Outcomes After Mitral Valve Surgery in Patients with Rheumatic vs. Non-Rheumatic Mitral Stenosis.

Authors:  S J Mirhosseini; Sadegh Ali-Hassan-Sayegh; Mehdi Hadadzadeh; Nafiseh Naderi; S M Y Mostafavi Pour Manshadi
Journal:  Heart Views       Date:  2012-10

8.  The role of exercise echocardiography in the management of mitral valve disease.

Authors:  R Jansen; P A M Kracht; M J Cramer; W J Tietge; L A van Herwerden; R J M Klautz; J Kluin; S A J Chamuleau
Journal:  Neth Heart J       Date:  2013-08-20       Impact factor: 2.380

9.  Repair versus replacement of mitral valves in cases of severe rheumatic mitral stenosis: mid-term clinical outcomes.

Authors:  Yuqing Jiao; Tiange Luo; Haibo Zhang; Jie Han; Yan Li; Yixin Jia; Shuai Zheng; Xu Meng
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

10.  Rheumatological findings in candidates for valvular heart surgery.

Authors:  Mohammad Bagher Owlia; Seyed Jalil Mirhosseini; Nafiseh Naderi; Seyed Mohammad Yousof Mostafavi Pour Manshadi; Sadeq Ali-Hasan-Al-Saegh
Journal:  ISRN Rheumatol       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.